Basingstoke, United Kingdom

Teresa Man



Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Teresa Man: Innovator in Norepinephrine Reuptake Inhibitors

Introduction

Teresa Man is a notable inventor based in Basingstoke, GB. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that can aid in the treatment of nervous system disorders. Her work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

One of Teresa Man's key patents is titled "Morpholine derivatives as norepinephrine reuptake inhibitors." This patent describes compounds of the general formula (I) that serve as inhibitors of norepinephrine reuptake. These compounds may be beneficial for treating various disorders affecting the central and peripheral nervous systems. Teresa holds 1 patent in this area, showcasing her expertise and dedication to advancing medical science.

Career Highlights

Teresa Man is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role involves research and development, where she applies her knowledge to create innovative therapeutic solutions. Her work at Eli Lilly has positioned her as a key player in the pharmaceutical industry, contributing to the advancement of treatments for complex health conditions.

Collaborations

Throughout her career, Teresa has collaborated with esteemed colleagues, including Gordon Iain Campbell and Manuel Javier Cases-Thomas. These collaborations have enriched her research and expanded the impact of her inventions in the medical field.

Conclusion

Teresa Man is a pioneering inventor whose work in norepinephrine reuptake inhibitors has the potential to transform treatment options for nervous system disorders. Her contributions to Eli Lilly and the pharmaceutical industry highlight her commitment to innovation and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…